531752 — Biogen Pharmachem Industries Share Price
0.000.00%
Last trade - 00:00- IN₹619.97m
- IN₹616.74m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.12 | ||
| Price to Tang. Book | 1.12 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.8% | ||
| Return on Equity | -1.31% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 16.23 | 24.74 | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +323.78 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biogen Pharmachem Industries Limited is an India-based company, which is not engaged in any activity. The Company is looking for the right opportunity to make the Company operational.
Directors
- Akshay Makadiya CFO
- Girishbhai Doshi CCO
- Jivan Kathe DRC
- Aishwarya Modi DRC
- Rakesh Patel DRC
- Rakesh Tewari DRC
- Udaybhai Patel NED
- Manishaben Muchhala IND
- Niraj Vaghela IND
- Gaurangkumar Vaishnav IND
- Jimish Soni NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 13th, 1995
- Public Since
- June 25th, 2001
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 652,603,000
- Address
- 603,Pratiksha complex, RAJKOT, 360001
- Web
- Phone
- +91 7927498832
- Auditors
- Rishi Shekhri & Associates
Upcoming Events for 531752
Q1 2026 Biogen Pharmachem Industries Ltd Earnings Release
Biogen Pharmachem Industries Ltd Annual Shareholders Meeting
Similar to 531752
Aadhaar Ventures India
Bombay Stock Exchange
Aagam Capital
Bombay Stock Exchange
Abans Enterprises
Bombay Stock Exchange
Abhijit Trading Co
Bombay Stock Exchange
Adarsh Mercantile
Bombay Stock Exchange
FAQ
What is the Biogen Pharmachem Industries share price?
As of Today at 19:36 UTC, shares in Biogen Pharmachem Industries are trading at IN₹0.95. This share price information is delayed by 15 minutes.
How has the Biogen Pharmachem Industries share price performed this year?
Shares in Biogen Pharmachem Industries last closed at IN₹0.95 and the price had moved by -18.1% over the past 365 days. In terms of relative price strength the Biogen Pharmachem Industries share price has underperformed the S&P BSE 100 Index by -24.22% over the past year.
What are the analyst and broker recommendations for Biogen Pharmachem Industries?
There is no consensus recommendation for this security.
Find out moreWhat is the Biogen Pharmachem Industries dividend yield?
Biogen Pharmachem Industries does not currently pay a dividend.
Does Biogen Pharmachem Industries pay a dividend?
Biogen Pharmachem Industries does not currently pay a dividend.
When does Biogen Pharmachem Industries next pay dividends?
Biogen Pharmachem Industries does not currently pay a dividend.
How do I buy Biogen Pharmachem Industries shares?
To buy shares in Biogen Pharmachem Industries you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Biogen Pharmachem Industries?
As of the previous close price of IN₹0.95, shares in Biogen Pharmachem Industries had a market capitalisation of IN₹619.97m.
Where are Biogen Pharmachem Industries shares listed?
Here are the trading details for Biogen Pharmachem Industries:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 531752
What kind of share is Biogen Pharmachem Industries?
Based on an overall assessment of its quality, value and momentum Biogen Pharmachem Industries is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Biogen Pharmachem Industries share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Biogen Pharmachem Industries share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biogen Pharmachem Industries. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -16.83%.
As of the last closing price of IN₹0.95, shares in Biogen Pharmachem Industries were trading -21.56% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Biogen Pharmachem Industries PE Ratio?
The Biogen Pharmachem Industries PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹0.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Biogen Pharmachem Industries?
Biogen Pharmachem Industries' management team is headed by:
- Akshay Makadiya - CFO
- Girishbhai Doshi - CCO
- Jivan Kathe - DRC
- Aishwarya Modi - DRC
- Rakesh Patel - DRC
- Rakesh Tewari - DRC
- Udaybhai Patel - NED
- Manishaben Muchhala - IND
- Niraj Vaghela - IND
- Gaurangkumar Vaishnav - IND
- Jimish Soni - NID